Skip to content
lifestyle.sli.mg
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
DBV Technologies S.A.
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
June 3, 2026
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
June 2, 2026
Combined General Meeting of June 3, 2026
May 21, 2026
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
May 21, 2026
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
February 12, 2026
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
February 11, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
February 11, 2026
←
Previous Page
1
2